A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular Carcinoma.
Herr DJ, Wang C, Mendiratta-Lala M, Matuszak M, Mayo CS, Cao Y, Parikh ND, Ten Haken R, Owen D, Evans JR, Stanescu T, Yan M, Dawson LA, Schipper M, Lawrence TS, Cuneo KC.
Herr DJ, et al. Among authors: evans jr.
Clin Cancer Res. 2023 Oct 2;29(19):3852-3858. doi: 10.1158/1078-0432.CCR-23-1044.
Clin Cancer Res. 2023.
PMID: 37471457
Free PMC article.
Clinical Trial.